The following article and research is courtesy of Panaxea. For men aged 50-69 years who underwent a one-time prostate-specific antigen (PSA) screening for prostate cancer, a lower prostate cancer-specific mortality was observed after 15 years of follow-up, but the reduction was only slight. Could this be due to the dissemination of cancer cells through prostate … Read more
The following academic report investigates the hypothesis whether ejaculation frequency affects prostate cancer. In terms of men’s health issues, prostate cancer features high on the agenda. It’s the second most diagnosed cancer in men globally – closely followed by lung cancer. And it’s the most common cancer in men in the UK. As the prostate is a reproductive organ … Read more
Benign Prostatic Hypertrophy (BHP) otherwise known as enlarged prostate, affects up to 60% of men over age 40. If there is also a rise in Prostate Specific Antigen (PSA) levels there may be real risk of malignancy. It is, therefore, important to know the risk factors – some of which can be identified in clinic … Read more
Ian Haines, Monash University, July 31, 2017 From the 1980s, when prostate screening became available, many men over 40 were diagnosed with early stage prostate cancer even though they may not have had any symptoms. The word cancer understandably strikes fear into the hearts of many, and most would assume the best course of action … Read more
